RxDoctor Payments Data

Kamran Parsa, DO

Neurological Surgery · Palmdale, CANPI 1982867669

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (55.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Nexxt Spine LLC accounts for 79.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $26,586, more than ten times the $569 reported in 2019.

$69,831in general payments, 2019–2025

Across 128 payments — averaging $545.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nexxt Spine LLC$56K
  • Aegis Spine, Inc.$10K
  • Boston Scientific$998
  • Spineart USA Inc$628
  • Nevro Corp.$478
  • Integrity Implants Inc. Dba Accelus$356
  • plus $2K from 17 others

What the payments were for

  • Royalty or licence$38,44655%
  • Consulting fees$11,52116%
  • Speaking & faculty fees$4,9737%
  • Travel & lodging$8,92713%
  • Food & beverage$5,9639%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,831 in reported general payments places this provider in the 85th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024
$181,088
Medicare patients
284
Services billed
669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin17$389
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$216
Tizanidine Hcl17$176
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$163
Lorazepam11$12

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Palmdale

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →